Global Epigenetics Market was worth USD 784.1 million in 2019 and is expected to reach USD 1499.0 million by 2024 with a CAGR of 13.84 %.
Epigenetics is the study of change in behavior of organism by modification of genetic expression rather than change in genetic code itself. Genes will get turned off or turned on depending on the circumstances, interactions etc. These turning on and off of genes differ in most of humans making humans unique. Some of these traits are passed down to future generations as heritable traits. The study of this entire mechanism is called Epigenetics.
Epigenetics is the study of potentially heritable changes in gene expression without a change in genetic sequence. These changes affect how cells read genes and how these genes are executed. These changes can be caused by various factors like Interactions, Circumstances, age etc. Epigenetic changes determine which cells should terminally differentiate to end up as skin cells or liver cells etc. Sometimes, they may cause diseases like cancer.
As humans grows and develops, depending on the interactions they made, circumstances they live in some genes become dormant or active to make who they are. Epigenetics is the study of these changes and factors that influence them. These changes decide how a cell should act and it may cause diseases like cancer sometimes. These epigenomes are sometimes inherited by their offspring.
Epigenetics is the study of changes in gene expression without any change in genetic sequence. These changes are affected by various factors like environment we live in, people we’ve interacted with and our age itself. These Epigenetics create differences in humans making every human unique. Some of these traits can be passed down to future generations.
Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the market. However, lack of trained professionals and high cost of instruments are some of the factors restraining the market.
Epigenetics Market is segmented based on Product and Research Area. Based on Product, market is segmented into Enzymes, Instruments & Consumables, KITS, and Reagents. Based on Research Area, market is segmented into Developmental Biology, Oncology, Drug Delivery. Based on Enzymes, market is further segmented into DNA-Modifying Enzymes, Protein-Modifying Enzymes, RNA-Modifying Enzymes. Further based on Instruments & Consumables, market is segmented into Mass Spectrometers, Next-Generation Sequencers, QPCR, Sonicators, and others. Based on KITS, market is further segmented into Bisulfite Conversion KITS, Chip-Sequence KITS, RNA Sequencing KITS, Whole-Genome Amplification KITS, 5-HMC and 5-MC Analysis KITS, others. Based on Reagents, market is further segmented into Antibodies, buffers, Histones, Magnetic Beads, Primers and others. Oncology segment holds the highest share in the market but drug discovery segment is expected to grow at highest CAGR during Forecast Period.
Geographically, market is further segmented into Asia-Pacific, Europe, North America, Latin America and Middle East and Africa. North America dominated the global market in 2018 owing to its advanced technology and presence of Major players. Asia-Pacific market is expected to grow at highest CAGR during the forecast period owing to the developing countries like India and China, and increasing R&D spending by companies.
Major players in the global epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Enzymes
5.1.2.1 DNA-Modifying Enzymes
5.1.2.2 Protein-Modifying Enzymes
5.1.2.3 RNA-Modifying Enzymes
5.1.3 Instruments & Consumables
5.1.3.1 Mass Spectrometers
5.1.3.2 Next-Generation Sequencers
5.1.3.3 QPCR
5.1.3.4 Sonicators
5.1.3.5 Others
5.1.4 KITS
5.1.4.1 Bisulfite Conversion KITS
5.1.4.2 Chip-Sequence KITS
5.1.4.3 RNA Sequencing KITS
5.1.4.4 Whole-Genome Amplification KITS
5.1.4.5 5-HMC and 5-MC Analysis KITS
5.1.4.6 Others
5.1.5 Reagents
5.1.5.1 Antibodies
5.1.5.2 buffers
5.1.5.3 Histones
5.1.5.4 Magnetic Beads
5.1.5.5 Primers
5.1.5.6 Others
5.1.6 Y-o-Y Growth Analysis, By Product
5.1.7 Market Attractiveness Analysis, By Product
5.1.8 Market Share Analysis, By Product
5.2 Research Area
5.2.1 Introduction
5.2.2 Developmental Biology
5.2.3 Oncology
5.2.4 Drug Delivery
5.2.5 Y-o-Y Growth Analysis, By Research Area
5.2.6 Market Attractiveness Analysis, By Research Area
5.2.7 Market Share Analysis, By Research Area
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Research Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Research Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Research Area
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Abcam plc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Illumina, Inc.
8.3 QIAGEN N.V.
8.4 Merck & Co.
8.5 New England Biolabs, Inc.
8.6 Zymo Research Corporation
8.7 Sigma-Aldrich Corporation
8.8 Thermo Fisher Scientific, Inc.
8.9 Active Motif
8.10 Diagenode, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
